Baxter’s North Cove plant located in Marion, North Carolina was significantly impacted by rain and flooding from Hurricane Helene. The facility specializes in the production of intravenous (IV) and peritoneal dialysis solutions and is the leading US manufacturer of these products.
View in browser
HcR-logo-tagline

North Cove Baxter Plant Situation Report

October 9, 2024  /  TLP:CLEAR 

Healthcare Ready is ENGAGED for this event. We are monitoring potential concerns for supply chain disruptions and impacts on healthcare services on our response page, listing resources and previous situation reports.

    Contents

    • Situation Overview and Key Updates
    • Impacts to Healthcare Supply Chain
    • About Healthcare Ready

    Highlights and Key Updates

    • Baxter’s North Cove plant located in Marion, North Carolina was significantly impacted by rain and flooding from Hurricane Helene. The facility specializes in the production of intravenous (IV) and peritoneal dialysis solutions and is the leading US manufacturer of these products.
      • On October 7, Baxter provided an infrastructure update on the North Cove plant, reporting no structural damage and anticipating engineering certification within two weeks. Power has been restored, the local water source is intact, and a temporary "rock bridge" supports transport, with a second bridge expected soon.
      • Baxter is continuing efforts to increase manufacturing capacity at its other sites. Their goal is to restart North Cove production in phases and return to 90% to 100% allocation of certain IV solutions by the end of the year.
    • On October 9, the Department of Health and Human Services (HHS) released a letter to health care stakeholders assuring that they are working with Baxter and other IV solutions manufacturers to address any potential gaps in the supply chain, mitigate impacts from Hurricane Helene and Hurricane Milton, and continuing to bolster the IV solutions supply chain.
      • This includes the FDA expediting assessments of alternative IV solutions and expediting shelf-life extension requests from manufacturers on short-dated products.

    Impacts to Healthcare Supply Chain

    • The following products are currently in shortage (pre-dating Hurricane Helene) and could be further constrained until the Baxter North Cove facility resumes operations:
      • Dextrose 5% IV solution
      • Dextrose 10% IV Solution
      • Sodium Chloride 0.9% IV Solution (Normal Saline)
      • Sodium Chloride 0.9% for Irrigation
      • Sterile Water for Injection
      • Sterile Water for Irrigation
      • The FDA has provided information on compounding drugs when appropriate if a drug is not available.
    • As of October 9, Baxter stated that they are implementing allocations of their highest demand IV fluids for:
      • Direct customers from 40% to 60%
      • Distributors from 10% to 60%
      • Additionally, Baxter stated allocations for IV solutions and nutrition products for designated children’s hospitals were increased to 100%.
    • In an effort to mitigate impacts, B. Braun, the second largest manufacturer of IV solutions in the US, increased production at both of their primary manufacturing sites (Daytona Beach, Florida and Irvine, California).
      • Braun’s manufacturing plant and distribution center in Daytona Beach, Florida, could be impacted by Hurricane Milton. The site primarily produces 0.9% Sodium Chloride for injection.
      • Both the plant and distribution center are currently closed, with plans to resume operations on Friday, October 11.
      • HHS ASPR is currently deploying assets to prepare for Hurricane Milton and move any IV solution products away from the projected path of the storm.
    • On October 7, the American Hospital Association (AHA) sent a letter to President Biden urging the Administration to take action to address the IV solution supply shortage caused by Hurricane Helene. AHA is requesting regulatory flexibility, an official shortage declaration, and measures to extend expiration dates or allow in-house mixing of IV fluids to support hospitals facing critical shortages.
      • On October 8, the American Society of Health-System Pharmacists (ASHP) sent a letter to HHS, ASPR, and FDA recommending expediting importation from foreign manufacturing sites, identifying alternative manufacturers, and ramping up additional domestic capacity. Additional recommendations on short-term and long-term resolutions and mitigation efforts can be found here.
      • It is anticipated that IV fluid shortages will remain or be further exacerbated during the next few months.

    About Healthcare Ready  


    Healthcare Ready is a 501(c)(3) nonprofit organization that works to ensure patient access to healthcare in times of disaster, emergency, and disease outbreaks. We leverage unique relationships with government, nonprofit and medical supply chains to build and enhance the resiliency of communities before, during and after disasters. Learn more about Healthcare Ready

    To request the help of our Emergency Operations Center, contact us at alerts@healthcareready.org.   

    Sign up here to receive email notifications from Healthcare Ready.

      FOLLOW US

      X
      Facebook
      LinkedIn

      Sign up to receive event-specific emails for your state or states where your organization operates

       

       For media inquiries please reach out to Alexis Wing at news@healthcareready.org.

      SUBSCRIBE

      Healthcare Ready leverages unique relationships with government, nonprofit and medical supply chains to build and enhance the resiliency of communities before, during and after disasters.  

       

      Healthcare Ready is approved by the Internal Revenue Service as a 501 (C)(3) tax-exempt organization, and all donations are tax deductible to the extent provided by law. Healthcare Ready's Federal Identification Number (EIN) is 46-3134601. 

      Healthcare Ready, 1325 G St NW Suite 500, Washington, DC 20005, United States

      Unsubscribe Manage preferences